BioWorld - Friday, December 26, 2025
To read the full story, subscribe or sign in.
US pediatric voucher making moves in Congress
Dec. 2, 2025
By Mari Serebrov
The next stop on the comeback tour for the U.S. FDA’s Rare Pediatric Disease Priority Review Voucher program is the Senate, after the House unanimously passed the Mikaela Naylon Give Kids a Chance Act, H.R. 1262, Dec. 1.
BioWorldRegulatoryU.S.FDALegislation